|
EP0312164A1
(en)
*
|
1987-10-16 |
1989-04-19 |
Merck & Co. Inc. |
Purification of recombinant epstein-barr virus antigens from vero cells, yeast cells or L cells
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
|
ATE509102T1
(de)
|
1994-07-15 |
2011-05-15 |
Univ Iowa Res Found |
Immunomodulatorische oligonukleotide
|
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
WO1998037919A1
(en)
|
1997-02-28 |
1998-09-03 |
University Of Iowa Research Foundation |
USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS
|
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
AU7690898A
(en)
|
1997-05-20 |
1998-12-11 |
Ottawa Civic Hospital Loeb Research Institute |
Vectors and methods for immunization or therapeutic protocols
|
|
ATE356630T1
(de)
|
1998-04-03 |
2007-04-15 |
Univ Iowa Res Found |
Verfahren und produkte zur stimulierung des immunsystems mittels immunotherapeutischer oligonukleotide und zytokine
|
|
WO2001075436A1
(en)
|
2000-04-03 |
2001-10-11 |
Board Of Trustees Of The Leland Stanford Junior University |
A method for protein structure alignment
|
|
WO2002016421A2
(en)
|
2000-08-18 |
2002-02-28 |
Research Foundation Of The State University Of New York |
Altered ospa of borrelia burgdorferi
|
|
EP1504037B1
(en)
|
2002-05-10 |
2009-12-30 |
New Century Pharmaceuticals, Inc. |
Ferritin fusion proteins for use in vaccines and other applications
|
|
US7774185B2
(en)
|
2004-09-14 |
2010-08-10 |
International Business Machines Corporation |
Protein structure alignment using cellular automata
|
|
JP5492418B2
(ja)
|
2005-11-18 |
2014-05-14 |
ザ オハイオ ステート ユニバーシティー リサーチ ファウンデーション |
ウイルス関連疾患を予防するためのウイルス遺伝子産物およびワクチン接種の方法
|
|
EP1997830A1
(en)
|
2007-06-01 |
2008-12-03 |
AIMM Therapeutics B.V. |
RSV specific binding molecules and means for producing them
|
|
US7951770B2
(en)
|
2007-06-13 |
2011-05-31 |
Northwestern University |
Peptides, peptidomimetics and small molecule inhibitors of the Epstein-Barr virus mediated fusion and entry process
|
|
AU2008339984A1
(en)
|
2007-12-21 |
2009-07-02 |
Glaxosmithkline Biologicals S.A. |
Vaccine
|
|
WO2009126816A1
(en)
|
2008-04-09 |
2009-10-15 |
Ventria Bioscience |
Production of ospa for lyme disease control
|
|
EP3705133B1
(en)
|
2010-05-14 |
2024-06-26 |
Baxalta Incorporated |
Ospa chimeras and use thereof in vaccines
|
|
WO2012006180A1
(en)
|
2010-06-29 |
2012-01-12 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Hiv immunogens
|
|
JP2013541507A
(ja)
|
2010-08-25 |
2013-11-14 |
ヘルムホルツ ツェントゥルム ミュンヘン ドイチェス フォルシュングスツェントゥルム フューア ゲズントハイト ウント ウムヴェルト （ゲーエムベーハー） |
エプスタイン・バール・ウイルスワクチン
|
|
EP2694109A4
(en)
|
2011-04-07 |
2015-02-18 |
Neotope Biosciences Ltd |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF PROTEIN AGGREGATION DISEASES WITH IC3B DEPOSITION
|
|
EP2515112B1
(en)
|
2011-04-22 |
2015-08-12 |
Sysmex Corporation |
Method for electrochemically detecting analyte
|
|
JP5795184B2
(ja)
|
2011-04-22 |
2015-10-14 |
国立大学法人 奈良先端科学技術大学院大学 |
被検物質の電気化学的検出方法
|
|
WO2013039792A1
(en)
|
2011-09-12 |
2013-03-21 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Immunogens based on an hiv-1 gp120 v1v2 epitope
|
|
CA2849822C
(en)
|
2011-09-23 |
2021-05-11 |
Gary J. Nabel, M.D. |
Novel influenza hemagglutinin protein-based vaccines
|
|
AU2013295647B2
(en)
*
|
2012-07-26 |
2018-02-08 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Multimeric fusion protein vaccine and immunotherapeutic
|
|
WO2014018931A1
(en)
*
|
2012-07-26 |
2014-01-30 |
The General Hospital Corporation |
Methods and compositions for treating autoimmune disease
|
|
FI2970398T3
(fi)
|
2013-03-13 |
2024-08-06 |
Us Health |
Rsv f -prefuusioproteiineja ja niiden käyttö
|
|
US10744199B2
(en)
|
2013-10-11 |
2020-08-18 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Epstein-Barr virus vaccines
|
|
AU2014362234B2
(en)
|
2013-12-11 |
2019-09-12 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Human herpesvirus trimeric glycoprotein B, protein complexes comprising trimeric gB and their use as vaccines
|
|
CZ2014320A3
(cs)
|
2014-05-09 |
2015-11-18 |
VÝZKUMNÝ ÚSTAV VETERINÁRNÍHO LÉKAŘSTVÍ, v.v.i. |
Polyepitopový antigen, vakcinační konstrukt a vakcína pro prevenci lymeské boreliózy
|
|
CA2950085A1
(en)
|
2014-05-27 |
2015-12-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Stabilized influenza hemagglutinin stem region trimers and uses thereof
|
|
SG11201705264WA
(en)
|
2014-12-31 |
2017-07-28 |
The Usa As Represented By The Secretary Detp Of Health And Human Services |
Novel multivalent nanoparticle-based vaccines
|
|
US9703095B2
(en)
|
2015-01-05 |
2017-07-11 |
Edward Pakhchyan |
Light modulator for MEMS display
|
|
EP3048114A1
(en)
|
2015-01-22 |
2016-07-27 |
Novartis AG |
Cytomegalovirus antigens and uses thereof
|
|
WO2016138160A1
(en)
|
2015-02-24 |
2016-09-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use
|
|
KR20180088458A
(ko)
|
2015-12-04 |
2018-08-03 |
다나-파버 캔서 인스티튜트 인크. |
암의 치료를 위한 mica/b 알파 3 도메인의 백신접종
|
|
US11174292B2
(en)
|
2016-03-29 |
2021-11-16 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Substitutions-modified prefusion RSV F proteins and their use
|
|
EP3463444B1
(en)
|
2016-06-07 |
2024-10-16 |
Deutsches Krebsforschungszentrum |
Improvement of hpv l2 peptide immunogenicity
|
|
FI3471760T3
(fi)
|
2016-06-17 |
2025-01-27 |
Boehringer Ingelheim Vetmedica Gmbh |
Lineaarisia tai haaroittuneita polyakryylihappopolymeeriadjuvantteja käsittäviä uusia immunogeenisiä formulaatioita
|
|
EP3474893A1
(en)
|
2016-06-27 |
2019-05-01 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigens
|
|
US11572389B2
(en)
|
2017-01-27 |
2023-02-07 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Vaccine compositions of herpesvirus envelope protein combinations to induce immune response
|
|
UA129243C2
(uk)
|
2017-04-19 |
2025-02-26 |
Інстітьют Фо Рісьорч Ін Біомедцін |
Антитіло, що зв'язується зі спорозоїтами p. falciparum
|
|
US11389529B2
(en)
|
2017-07-13 |
2022-07-19 |
City Of Hope |
Expression system for expressing herpesvirus glycoprotein complexes
|
|
US11964006B2
(en)
|
2017-09-16 |
2024-04-23 |
City Of Hope |
Multivalent Epstein-Barr virus-like particles and uses thereof
|
|
EP3713601A4
(en)
|
2017-11-21 |
2022-03-09 |
Modernatx, Inc. |
VACCINES AGAINST EPSTEIN-BARR VIRUS
|
|
WO2019161163A1
(en)
|
2018-02-16 |
2019-08-22 |
The Wistar Institute Of Anatomy And Biology |
Epstein-barr virus nucleic acid constructs and vaccines made therefrom, and methods of using same
|
|
CN112512564A
(zh)
|
2018-04-03 |
2021-03-16 |
赛诺菲 |
铁蛋白蛋白
|
|
CA3095174A1
(en)
|
2018-04-03 |
2019-10-10 |
Sanofi |
Antigenic ospa polypeptides
|
|
BR112020019938A2
(pt)
|
2018-04-03 |
2021-01-26 |
Sanofi |
polipeptídeos antigênicos de vírus sincicial respiratório
|
|
CN112512565A
(zh)
|
2018-04-03 |
2021-03-16 |
赛诺菲 |
抗原性流感-铁蛋白多肽
|
|
CN112512566A
(zh)
|
2018-04-03 |
2021-03-16 |
赛诺菲 |
抗原性爱泼斯坦-巴尔病毒多肽
|
|
EP4225360A1
(en)
|
2020-10-08 |
2023-08-16 |
Virothera Limited |
Vaccine compositions
|
|
US20230016245A1
(en)
|
2021-07-16 |
2023-01-19 |
California Institute Of Technology |
Stoichiometric expression of messenger polycistrons
|